New potential drug targets discovered for preventing prostate cancer cell growth
Researchers from VTT Technical Research Centre of Finland and the University of Turku have discovered four metabolic enzymes regulating prostate cancer cell growth. Inhibition of these enzymes prevents prostate cancer cell growth in cultured cells. This knowledge can be used to identify different subtypes of prostate cancer and for designing targeted therapies for prostate cancer.Eicosanoid hormones, which are metabolites of arachidonic acid found in animal-based foods, such as eggs and meat, are essential regulators of normal bodily functions. Metabolic dysfunction relating to these